Related Experiment Video
Updated: Apr 24, 2026

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
7.0K
Laboratory Medicine Approaches for Assessing Delayed Graft Function in Renal Transplant
Tiffany K Bratton1,2,3, Annalara G Fischer1, Christopher T Burns4
1Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, United States.
The Journal of Applied Laboratory Medicine
|April 22, 2026
Summary
Predicting delayed graft function (DGF) in kidney transplants is crucial. Emerging biomarkers and AI modeling offer promising tools for early detection and improved organ allocation, enhancing transplant outcomes.
Area of Science:
- Nephrology
- Transplantation immunology
- Biomarker discovery
Background:
- Delayed graft function (DGF) is a major complication in renal transplantation, impacting graft survival and healthcare costs.
- Optimizing donor organ selection and post-transplant outcomes are critical as kidney transplantation rates increase.
- Early identification and prediction of DGF are essential for timely interventions.
Purpose of the Study:
- To review the causes, risk factors, and consequences of DGF.
- To highlight emerging biomarkers for early DGF detection and risk stratification.
- To explore the role of artificial intelligence in predictive modeling for kidney transplantation.
Main Methods:
- Review of multifactorial causes and determinants of DGF (ischemia-reperfusion injury, donor/recipient factors).
- Examination of novel biomarkers: neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, proenkephalin, and interleukin-18.
- Exploration of artificial intelligence integration into predictive models combining diverse variables.
Main Results:
- Emerging biomarkers show promise for early DGF detection and risk stratification.
- AI-driven predictive models can integrate molecular, clinical, and procedural data.
- Improved organ allocation and individualized patient management are potential outcomes.
Conclusions:
- Assessing biomarkers preoperatively in donors can provide earlier insights into organ quality.
- Standardization of biomarker measurement is necessary for reliable prediction.
- Enhanced donor characterization is key for clinical translation of predictive tools.
Related Concept Videos
Kidney Transplant I: Introduction
815
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
815
Kidney Transplant II: Surgical Procedure
913
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
913
Kidney Transplant III: Nursing Management
624
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
624
Acute Kidney Injury III: Clinical Manifestations
1.6K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K

